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Abstract
Introduction: Spine stereotactic body radiation therapy (SBRT) achieves favorable outcomes
compared to conventional radiotherapy doses/fractionation. The spinal cord is the principal
dose-limiting organ-at-risk (OAR), and safe treatment requires precise
immobilization/localization. Therefore, image guidance is paramount to successful spine SBRT.
Conventional X-ray imaging and alignment to surrogate bony anatomy may be inadequate,
whereas magnetic resonance imaging (MRI) directly visualizes the dose-limiting cord. This
work assessed the dosimetric capability of the ViewRay (ViewRay Inc. Oakwood Village, OH)
magnetic resonance (MR) guided linac (MR-Linac) for spine SBRT.
Methods: Eight spine SBRT patients without orthopedic hardware who were previously treated
on a TrueBeam using volumetric modulated arc therapy (VMAT) were re-planned using MRLinac fixed-field intensity-modulated radiation therapy (IMRT). Phantom measurements using
film, ionization chamber, and a commercial diode-array assessed feasibility. Plans included a
variety of prescriptions (30-50 Gy in 3-10 fractions).
Results: MR-Linac plans satisfied all clinical goals. Compared to VMAT plans, both entrance
dose and heterogeneity increased (Dmax: 134±3% vs. 120±2%, p=0.0270), while conformality
decreased (conformity index: 1.28±0.06 vs. 1.06±0.06, p=0.0005), and heterogeneity increased.
However, while not statistically significant, MR-linac cord sparing improved (cord Dmax:
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16.1±2.7Gy vs. 19.5±1.6Gy, p=0.2066; cord planning organ at risk volume (cord PRV) D max:
20.0±2.6Gy vs. 24.5±2.0Gy, p=0.0996). Delivery time increased but was acceptable
(14.39±1.26min vs. 9.57±1.19min). Ionization chamber measurements agreed with planned dose
to within 2.5%. Film and diode measurements demonstrated accurate/precise delivery of dose
gradients between the target and the cord.
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Conclusion: Spine SBRT with the MR-Linac is feasible as verified via re-planning eight clinical
cases followed by delivery verification in phantoms using film, diodes, and an ionization
chamber. Real-time visualization of the dose-limiting cord during spine SBRT may enable cordbased gating, reduced margins, alternate dose schemas, and/or adaptive therapy.
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Introduction
Nearly 40% of cancer patients present with clinically symptomatic spinal disease and ~90%
demonstrate evidence of disease upon autopsy [1]. Treatment options include systemic therapy,
surgery, radiation therapy (RT), or surgery+RT, with goals of pain palliation, bone fracture
avoidance, and/or management of neurological symptoms and disease progression [2]. In many
settings, surgery+RT is standard of care. Ablative stereotactic body RT (SBRT) may provide
improved efficacy compared to conventional fractionation [1]. Furthermore, spine SBRT has
improved potential for retreatment and dose escalation for radioresistant disease.
Accuracy and precision are paramount to spine SBRT, thereby emphasizing patient
immobilization and image guidance. The primary dose-limiting organ-at-risk (OAR) is the
spinal cord. Cord definition is usually from magnetic resonance imaging (MRI) (or computed
tomography (CT) myelography). Cord delineation uncertainty, inability to visualize/immobilize
the cord during treatment, and the importance of respecting cord tolerances often lead to a cord
planning organ-at-risk volume (PRV). Use of PRV margin, typically 1-2 mm, decreases disease
coverage [1]. Prior to image-guided RT (IGRT), a framed approach provided immobilization for
linac-based spine SBRT [3]. Initial IGRT attempts used a vacuum bag immobilization device and
ultrasound [4]. Real-time image guidance (orthogonal kVs) with Cyberknife enabled frameless
spine SBRT by providing setup uncertainties of 1.0-1.2 mm [5-6]. Similar approaches are now
widely adopted using traditional linac approaches and kV image guidance (2D planar images
and/or 3D cone beam CT (CBCT)).
An issue with conventional kV imaging is that positioning tends to rely on bony anatomy,
which is a surrogate for the anatomy of interest (e.g., tumor or cord). MRI can address this and
already has important roles in RT, specifically spine SBRT [1-2]. Factors limiting utilization of
MRI in RT (e.g., logistics of having a dedicated MRI, geometric distortion, availability during
treatment), have mostly been addressed with the advent of MR guided RT (MRgRT) [7-8]. One
such implementation is the MRidian MR-linac (ViewRay Incorporated, Oakwood Village, OH)
[7]. The utility of MRidian images has been compared to CT and on-board CBCT. No significant
volumetric differences were found between contours drawn using CT versus ViewRay MRI [9].
Compared to on-board CBCT, MRIdian images were mostly superior, with the major
shortcoming being bony anatomy visualization, which is less pertinent when soft tissue (e.g.,
cord) is directly identifiable [10].
The MRIdian MR-linac system (6MV flattening filter free) has improved dosimetric qualities
compared to a prior cobalt-based system (e.g., higher multileaf collimator (MLC) resolution,
improved penetration, decreased penumbra, faster treatment) [11-14]. Specifically, the MRlinac system’s MLCs have a width of 8.3 mm but are double-stacked and offset to provide a 4.15
mm effective leaf width, versus 10.5 mm for the cobalt system. MLCs for both systems are
double-focused (see [15] for details on system technical specifications). One planning study
with the 60 Co MRIdian suggested that spine SBRT was not dosimetrically feasible [13]. MRgRT
spine SBRT may be feasible with the MR-linac system, and may improve upon kV-based IGRT
approaches. Preliminary data suggests that aligning to vertebra versus cord, which is visible
with MRIdian, requires an average shift of 0.9 mm (up to 1.8 mm observed; no obvious time
trends) [16].
This work demonstrates the dosimetric feasibility of spine SBRT with the ViewRay MR-Linac
system, which may enable visualization of the dose limiting spinal cord during treatment and
allow cord-based gated delivery and/or online adaptive spine SBRT. Eight spine SBRT plans
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(clinically planned using VMAT on a conventional linac) are compared to MR-Linac plans.
Fidelity between planned and delivered MR-linac dose distributions is verified using phantom
measurements with film, diodes, and ion chambers.

Materials And Methods
Clinical cases
Eight spine SBRT plans recently treated in our clinic were re-planned in the ViewRay treatment
planning system (TPS). Plans included prescription doses ranging from 30 to 50 Gy and
fractionation schemes ranging between three and ten fractions. One plan incorporated a
simultaneous integrated boost. PTV sizes ranged from 25-160 cc. PTV extent ranged from
anterior vertebral body only, to various combinations of pedicle, transverse process and
spinous process coverage (see Figure 1 for delineation of regions of potential disease extent;
see Table 1 for corresponding descriptions of targets used in this work), based upon the
international spine radiosurgery consortium target volume guidelines [2].

FIGURE 1: Spinal Vertebrae Diagram
Diagram of spinal vertebrae (axial plane) showing different regions by which to describe the extent
of the planning target volume (PTV) to be treated. 1 = vertebral body, 2 = left pedicle, 3 = left
transverse process, 4 = spinous process, 5 = right transverse process, 6 = right pedicle. The spinal
canal containing the spinal cord is shown as the central white oval area.
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Case # (Vertebral

PTV Volume

PTV

Prescription Dose /

PTV Clinical Coverage

Level)

[cc]

Extent

Fractionation

Goal(s)

1 (T)

60.2

1, 2, 6

30Gy / 3fx

V100% > 95%

2 (T)

119.9

50Gy / 5fx

V100% > 80% ; V90% > 95%

3 (T)

38.2

30Gy / 3fx

V100% > 95%

4 (L/S)

160.3 (9.1)

30(40)Gy / 5fx

V100% > 95%

5 (T)

36.3

30Gy / 3fx

V100% > 90% ; V90% > 98%

6 (L)

73.7

1, 2, 6

30Gy / 3fx

V100% > 90% ; V90% > 98%

7 (L)

25.8

1

30Gy / 3fx

V100% > 95%

8 (T)

71.2

30Gy / 3fx

V100% > 90%

1, 2, 3, 5,
6
1, 2, 4, 5,
6
1, 2, 4, 5,
6
1, 2, 3, 4,
6

1, 2, 4, 5,
6

TABLE 1: Plan Characteristics
Description of treatment plans included in this study. Plan #4 included a simultaneous integrated boost, which is indicated by the
additional volume and Rx dose in parenthesis.

Planning approach
The principal dose-limiting OARs were the spinal cord and esophagus. Cord OAR definition was
either based on CT myelogram (n=6) or substituted with spinal canal (n=2). Cord planning
organ at risk volume (PRV) used a 1 mm expansion. When spinal canal was a cord surrogate, no
PRV expansion was used. Some plans were treating regions in the lumbar/sacral vertebral level,
where cord transitions to cauda equina, however, for generality, this distinction is not made
(i.e., cauda = cord). Secondary OARs include esophagus, bowel, liver, and lungs. These were not
dose-limiting and are not presented in the following analyses. OAR goals were from the
American Association of Physicists in Medicine (AAPM) TG-101 [17]. All images and structures
(targets, OARs, PRVs) were consistent between clinical VMAT plans and MR-Linac plans.
Conventional linac plans were VMAT and used a Varian TrueBeam accelerator with HDMLC and
a 6MV beam. The plans used 2-4 co-planar arcs. PTV coverage goals were V 100% > 95% unless
OAR constraint(s) precluded this, in which case either fractionation was reconsidered or lower
PTV coverage was accepted. Eclipse v11 (n=7) (Varian Medical Systems, Inc., Palo Alto, CA) or
Pinnacle v9 (n=1) (Philips Radiation Oncology Systems, Fitchburg, WI) were used. Dose was
calculated with 1 mm resolution, using homogeneity correction (collapsed cone convolution
superposition in Pinnacle and Acuros in Eclipse).
Fixed-field IMRT was adopted for the MR-Linac plans, with nine equally-spaced co-planar
beams, starting with a gantry angle of 0o . Due to limited space within the MR-Linac bore, the
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VMAT isocenter could not always be replicated. For these cases, isocenter was as close to the
middle of the treated vertebral body as possible. Plans were calculated using 1mm resolution,
similar to conventional linac plans, using the ViewRay TPS advanced implementation (enabling
dose volume histogram (DVH)-based planning constraints) and Monte Carlo dose computation
algorithm (1% dose uncertainty).

Plan evaluation
Dosimetric endpoints comparing MR-Linac and conventional linac plans included both PTV
and OAR considerations. For the PTV, these were target coverage (V100%, V95%, and V90%),
maximum dose (D max) for heterogeneity, and conformity index (CI = V Rx /VPTV, where VRx is
the prescription isodose volume and V PTV is PTV volume). For the OARs/PRVs, these consisted
of Dmax and organ specific dose-volume thresholds (e.g., spinal cord V 12.3Gy and V18Gy ,
esophagus V17.7Gy, bowel V17.4Gy, liver V30Gy , and lung V20Gy ). TPS calculated beam-on time
was also evaluated. Statistical significance was determined using a two-tailed paired-samples ttest.

Phantom measurements
To evaluate deliverability/accuracy of the plans and TPS calculated dose distributions, various
dosimetric measurements were made for two of the eight cases, representing two ends of the
spectrum of PTV geometric complexity. These cases were #7, with the PTV solely including the
vertebral body (i.e., a simple target) and #8 with the PTV fully wrapped around the spinal cord
(i.e., the most challenging target). Dosimeters were radiochromic film, a commercial quality
assurance (QA) diode array, and an ionization chamber.
EBT3 Gafchromic film (Ashland Specialty Ingredients, NJ) provided a high-resolution
comparison between planned and delivered dose. The accuracy of film for measurements in
relatively high magnetic field environments has been established [18-19]. Film sheets
(10×10 cm2) were placed at the center of a 30×30×30cm 3 water-equivalent plastic phantom
(Solid Water, Gammex, Middleton, WI). Film was exposed when oriented in axial, sagittal, and
coronal planes. To avoid saturation, QA plans were scaled so that maximum dose was
<1000 cGy. Treatment fields were re-cast onto a CT of this phantom and the calculated planar
dose corresponding to film location/orientation was used for comparison. The RIT software
package (Radiological Imaging Technology, Colorado Springs, CO) was used for dosimetric
comparison via global gamma analysis with 3%/3mm and 2%/2mm criteria (10% low-dose
threshold). Planned dose distribution was resampled to the higher film resolution (scanned
using red channel, 150 dots per inch (DPI)).
The plans were also measured using the commercially-available, MR-compatible ArcCHECK
phantom (Sun Nuclear Corporation, Melbourne, FL) with an Accredited Dosimetry Calibration
Laboratory (ADCL) calibrated ionization chamber (Exradin A18MRI, Standard Imaging,
Middleton, WI, collecting volume 0.123 cc) placed in the central insert. The ArcCHECK
(consisting of a helical diode array) with ion chamber represents a common approach to routine
patient-specific QA with the MR-Linac [19-20]. Previous studies have demonstrated accuracy of
using this ion chamber in the presence of the 0.35 T magnetic field [19-21]. Treatment fields
were re-cast onto the cylindrical ArcCHECK phantom in the TPS and the SunNuclear QA
software used the resulting RTdose DICOM file to extract the planned dose plane corresponding
to the cylindrical surface within the phantom containing the diode array. Comparison between
planned and measured dose surfaces was performed using the same global gamma criteria
(3%/3mm and 2%/2mm criteria, with a 10% low-dose threshold).
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Results
Planning comparison
A representative case comparing the clinical VMAT and MR-linac plans is in Figure 2. The MRlinac plans spare the cord well but are less conformal (see isodose lines bowing out compared to
VMAT plan, particularly near PTV distal to cord). The fixed-field IMRT approach for MR-linac
planning exhibits more appreciable low-dose along beam directions.

FIGURE 2: Qualitative Dosimetric Comparison
Qualitative dosimetric comparison of isodose distribution for case #5 clinical volumetric modulated
arc therapy (VMAT) plan (left) and corresponding magnetic resonance guided linac (MR-Linac) plan
(right). The planning target volume (PTV) is the blue shaded region.

A comprehensive quantitative comparison of overall trends for all cases considered is in Figure
3. All MR-linac plans are clinically acceptable by our institutional spine SBRT protocol. There
are no significant differences in target coverage (average PTV V100 of MR-linac vs. clinical
VMAT are 92.7% [range: 85.9-95.9%] vs. 92.3% [range: 81.2-98.95%], respectively, p=0.7572).
The higher conformity index demonstrates significantly inferior conformity for the MR-linac vs.
VMAT plans (1.28±0.06 vs. 1.06±0.06, respectively, p=0.0005). Increased Dmax shows
significantly increased heterogeneity for MR-linac vs. VMAT plans (134±3% vs. 120±2%,
respectively, p=0.0270). While not statistically significant, MR-linac plans show trends of lower
cord doses compared to VMAT plans (cord Dmax of 16.1±2.7 Gy vs. 19.5±1.6 Gy, p=0.2066, and
cord PRV Dmax of 20.0±2.5 Gy vs. 24.5±2.0Gy, p=0.0996, for MR-linac vs. VMAT). Volumetric
planning goals for the cord, cord PRV, spinal canal, and esophagus were comparable with no
significant differences.
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FIGURE 3: Quantitative Dosimetric Comparison
Quantitative dosimetric comparison of planning target volume (PTV) parameters displayed in (a),
Organ-at-risk/Planning-organ-at-risk-volume (OAR/PRV) max dose parameters are displayed in
(b), and OAR/PRV dose-volume parameters are displayed in (c). Asterisks indicate statistically
significant (p<0.05) differences. Differences are magnetic resonance guided-linac (MR-Linac) minus
volumetric modulated arc therapy (VMAT) values. Error bars show standard deviation of this
difference.

Plan deliverability
The planning comparison in Figure 2 and Figure 3 demonstrate a theoretical capability of the
ViewRay MR-Linac to produce spine SBRT plans meeting clinical goals for various targets. To
validate true deliverability, phantom measurements with various dosimeters assessed fidelity
to planned dose distributions.
One aspect of deliverability is treatment time. Planning strategies avoiding excessive delivery
times on the MR-linac are necessary. The number of segments during optimization was
restricted and the IMRT “efficiency” parameter within the TPS was increased to encourage
larger beam segments. The MR-linac plans consisted of the same nine gantry angles (40o
separation starting at 0o ). The number of segments per IMRT beam were 9.21±0.48 (range: 221). The planning system calculated beam on time was 12.75±1.27 minutes (range: 8.85-17.92
minutes). Including gantry and MLC motion, the MR-linac treatment times were 14.39±1.26
minutes (range: 10.08-18.96 minutes), compared to the clinical VMAT treatment times of
9.57±1.19 minutes (p=0.0202). The MR-linac treatment times are significantly longer, but are
still clinically reasonable.
Table 2 summarizes the phantom measurement results for cases #7 and #8 (representing the
spectrum of potential PTV geometries, see Table 1 and Figure 1). Gamma passing rates for the
diode array phantom and the film measurements are excellent with 3%/3mm and acceptable
with 2%/2mm. Ion chamber measurements at a single point shows clinically acceptable fidelity
(< 3% difference).
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ArcCHECK

Film
Ion Chamber (Dose Difference)

Gamma Criteria:

3%/3mm

2%/2mm

3%/3mm

2%/2mm

Case #7

100.0%

99.3%

98.0%

92.7%

+ 0.7%

Case #8

99.4%

95.3%

96.4%

89.3%

+ 2.5%

TABLE 2: Phantom Measurement Results
Summary of results comparing measured to planned doses for cases #7 and #8. Gamma passing rates for both ArcCHECK diode and
radiochromic film measurements using various gamma criteria are shown as well as a relative dose difference between ion chamber
measured and planned dose.

Film analysis is shown in Figure 4 and Figure 5 for cases #7 and #8, respectively. In Figure 5, the
low-dose region for spinal cord sparing can be seen inside of the high-dose region used to treat
the disease. Orthogonal dose profiles in Figure 4 and Figure 5 show closely matching spatial
doses, which is particularly impressive in the high-gradient regions between the target and
spinal cord. Regions failing gamma analysis for 3%/3mm and 2%/2mm criteria are shown in red
in Figures 4e-4f and Figures 5e-5f. Figure 4g and Figure 5g shows similar dose profiles from
diode array measurements.

FIGURE 4: Case #7 - Simple PTV Geometry
Spatial dosimetry results for case #7 representing simple planning target volume (PTV) geometry.
(a) Planned and (b) measured planar dose distributions. (c) Vertical and (d) horizontal dose profiles
along the red and green lines, respectively, shown in (a) and (b). Solid lines are measured profiles,
dotted lines are planned profiles, and the blue line in (c) and (d) shows the difference between the
two. Gamma analysis results when using either 3%/3mm or 2%/2mm criteria are shown in (e) and
(f), respectively. Measured dose distribution is shown in grayscale and red points indicate a gamma
value > 1 (i.e., failing points). (g) Representative dose profiles showing ArcCHECK diode measured
(circles) versus planned (solid line) dose distributions. Yellow filled circles pass gamma analysis and
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blue/red filled circles fail with lower/higher measured dose.

FIGURE 5: Case #8 - Complex PTV Geometry
Spatial dosimetry results for case #8 representing a complex planning target volume (PTV)
geometry. (a) Planned and (b) measured planar dose distributions. (c) Vertical and (d) horizontal
dose profiles along the red and green lines, respectively, shown in (a) and (b). Solid lines are
measured profiles, dotted lines are planned profiles, and the blue line in (c) and (d) shows the
difference between the two. Gamma analysis results when using either 3%/3mm or 2%/2mm criteria
are shown in (e) and (f), respectively. Measured dose distribution is shown in grayscale and red
points indicate a gamma value > 1 (i.e., failing points). (g) Representative dose profiles showing
ArcCHECK diode measured (circles) versus planned (solid line) dose distributions. Yellow filled
circles pass gamma analysis and blue/red filled circles fail with lower/higher measured dose.

Discussion
Recent work found the MR-linac to be capable of cranial stereotactic radiosurgery (SRS) [18].
Extracranial or spinal SRS/SBRT utilizes similar margins (~1 mm) and requires similar
precision/accuracy. This is facilitated by improvements between the 60 Co and MR-linac
iterations including: 6MV flattening filter free (FFF) beam (decreased penumbra, lower surface
dose, higher penetration, and non-decaying 600 cGy/min dose rate), a 138 leaf double-stacked
double-focused MLC system (effectively projecting to 0.415 cm rather than 1.05 cm at
isocenter, enabling 0.2 cm x 0.4 cm field sizes and decreasing interleaf leakage) [15,18]. The
relatively low magnetic field (0.35 T) decreases distortion and provides imaging accuracy better
than 1 mm with registration accuracy on the order of a single voxel (~1.5 mm) [22].
Preliminary studies show that the ViewRay MRIdian linac can visualize the cord/cauda versus
surrounding thecal sac [16]. While spine SBRT patients have been successfully and safely
treated with current non-MRgRT approaches, most rely on bony anatomy as a surrogate for the
true OAR (cord). PRV expansion partly accounts for cord motion independent of surrounding
vertebra. However, registering images capturing intrafraction motion to initial planning images
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based on bony anatomy or the cord itself resulted in average setup differences of 0.9 mm (up to
1.8 mm) [16]. This suggests that we can improve spine SBRT by registering directly to the spinal
cord. With no clear time trends to such motion, continuous/real-time image guidance, as
provided by MR-linac may be necessary [16]. A system that can visualize the dose-limiting cord
in real-time potentially enables cord-based gating. However, this may lengthen treatment
times.
Different general approaches to online adaptive RT are discussed in the literature [7,23-25]. The
work presented herein argues for spine SBRT implementation on the MRIdian MR-linac
platform, but the proper adaptive approaches must be determined. Online plan reoptimization
for spine SBRT must be investigated as has been done for other sites [24-26]. More accurate
image guidance, gating, and/or adaptive RT for spine SBRT on the MR-linac may enable reduced
margins and dose escalation for improved efficacy.
Compared to conventional linac VMAT plans, increased heterogeneity (greater Dmax) and
inferior conformality (particularly for intermediate/lower isodoses) found in this work are
consistent with previous studies [12]. It is important to emphasize that the heterogeneity,
while higher for the MR-linac plans, was found to be clinically acceptable for treatments of this
nature, as it facilitates the necessary steep dose fall off to spare the nearby spinal cord. For this
work, nine equally-spaced, fixed IMRT fields were used. Prior studies found no significant
improvements with greater than nine beams [27]. While presented results show dosimetric
capabilities needed for spine SBRT, approaches may be improved (e.g., plan specific beam
angles, off-axis treatments approximating non-coplanar beams, alternative optimization
approaches, additional delivery efficiency considerations, etc.). Clinical VMAT plans had more
freedom to utilize variable numbers of arcs (2-4), collimator angles, etc., based on target
geometry and relationship to nearby OARs. Target and OAR contours were kept consistent
between clinical VMAT and MR-linac plans. Other planning studies have incorporated assumed
benefits of MRgRT on PTV/PRV margins and utilized smaller targets in the MRgRT plans,
providing a dosimetric advantage [11,13-14]. In fact, the previous study exploring spine SBRT
for the Cobalt system used this approach (VMAT: 1 mm cord PRV vs. ViewRay: cord PRV = true
cord). Regardless, while the cord was well-visualized, dosimetry was inadequate [13]. The single
fraction prescription of 18 Gy was decreased to 12.6 Gy on average to respect cord tolerance
(versus 17.5 Gy for VMAT, which used an additional 1 mm margin for cord PRV). Average beamon time (48.82 minutes) was clinically unacceptable [13]. With the MR-linac, target coverage is
comparable to VMAT and clinically acceptable in all cases. While beam on time is longer than
for VMAT, beam-on times with the 6MV FFF beam are acceptable (12.75±1.27 minutes), and
related intrafraction motion issues arising from longer treatment times could potentially be
offset by leveraging the OAR-based real-time tracking capabilities of the MR-Linac. Note,
conventional linac plans used a 6MV beam (max dose rate of 600 MU/min), but if 6MV FFF
(max dose rate of 1400 MU/min) were utilized, average treatment time (9.57±1.19 min) would
decrease. It should be noted that the treatment planner was different for the MR-Linac plans
and the clinical VMAT plans and that the MR-Linac planner was not necessarily blinded to the
dosimetry of the baseline clinical VMAT plans.
Many spine SBRT patients require orthopedic hardware for spinal stabilization. While MRcompatible, it is unclear how susceptibility artifacts may affect MRgRT spine SBRT. However, a
study investigating the MRIdian for high-dose rate (HDR) brachytherapy planning found
decreased artifacts from applicators/instruments in 0.35 T versus higher-field diagnostic MRI
[28]. MRI provides both functional and anatomical information. Diffusion-weighted imaging
has already been demonstrated on the MRIdian [29]. As pulse-sequence options continue to
expand, so will interesting clinical applications.

Conclusions
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This work demonstrates the feasibility of spine SBRT with fixed-field IMRT on the ViewRay
MR-linac. Compared to clinical VMAT plans on a conventional linac, MR-linac plans had
increased heterogeneity, lower conformality and longer beam-on. However, MR-linac plans
were dosimetrically clinically acceptable and, while not statistically significant, tended to have
improved cord sparing. Phantom measurements of delivered doses with an ion chamber, film,
and diode array show good fidelity with planned doses, particularly in the regions between
target and cord with large dose gradients, ensuring that the dose distributions are deliverable.
MRgRT Spine SBRT is an application that may allow direct visualization of the dose-limiting
spinal cord in real-time during treatment for reduced margins, dose escalation, gating, and/or
adaptive radiotherapy.
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